In8bio Plunges 16.07% on Negative EPS Outlook

On June 9, 2025, In8bio's stock experienced a significant drop of 16.07% in pre-market trading, reflecting a notable decline in investor sentiment.

Analysts have revised their expectations for In8bio, projecting a negative earnings per share (EPS) of -0.56 for the current year. This downgrade in earnings outlook has likely contributed to the recent decline in the company's stock price.

In8bio's share price, as of June 9, 2025, stands at €2.97. The company's earnings per share (EPS) for the trailing twelve months ended in March 2025 were negative, which may have influenced investor decisions and led to the stock's recent performance.

Despite the current challenges, In8bio has shown relative strength compared to other companies in certain financial metrics, such as sales, sales growth, and profit growth. This comparative performance may offer some reassurance to investors, although the immediate market reaction suggests ongoing concerns about the company's financial health.